Edrophonium (BioDeep_00001868420)

Main id: BioDeep_00000006390

 


代谢物信息卡片


Edrophonium

化学式: C10H16NO+ (166.1232)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC[N+](C)(C)C1=CC(=CC=C1)O
InChI: InChI=1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1

描述信息

D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors
C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor
D020011 - Protective Agents > D000931 - Antidotes
V - Various > V04 - Diagnostic agents
D004791 - Enzyme Inhibitors

同义名列表

2 个代谢物同义名

Edrophonium; Edrophonium



数据库引用编号

11 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Yukio Sugiyama, Yoshiki Esa, Akihiro Watanabe, Junya Kobayashi, Shigeaki Suzuki, Daisuke Takahashi. [Immune checkpoint inhibitor-induced anti-striational antibodies in myasthenia gravis and myositis: a case report]. Rinsho shinkeigaku = Clinical neurology. 2021 Sep; 61(9):630-634. doi: 10.5692/clinicalneurol.cn-001604. [PMID: 34433744]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Ramachandra S Naik, Tatyana Belinskaya, C R Vinayaka, Ashima Saxena. Monoclonal antibodies to fetal bovine serum acetylcholinesterase distinguish between acetylcholinesterases from ruminant and non-ruminant species. Chemico-biological interactions. 2020 Oct; 330(?):109225. doi: 10.1016/j.cbi.2020.109225. [PMID: 32795450]
  • Edoardo Fabini, Anna Tramarin, Manuela Bartolini. Combination of human acetylcholinesterase and serum albumin sensing surfaces as highly informative analytical tool for inhibitor screening. Journal of pharmaceutical and biomedical analysis. 2018 Jun; 155(?):177-184. doi: 10.1016/j.jpba.2018.03.060. [PMID: 29635172]
  • Terrone L Rosenberry, Patricia K Martin, A Jeremy Nix, Scott A Wildman, Jonah Cheung, Scott A Snyder, Ren Xiang Tan. Hopeahainol A binds reversibly at the acetylcholinesterase (AChE) peripheral site and inhibits enzyme activity with a novel higher order concentration dependence. Chemico-biological interactions. 2016 Nov; 259(Pt B):78-84. doi: 10.1016/j.cbi.2016.05.032. [PMID: 27297626]
  • Jee-Ae Kim, Young-Min Lim, Eun Hye Jang, Kwang-Kuk Kim. A patient with coexisting myasthenia gravis and lambert-eaton myasthenic syndrome. Journal of clinical neurology (Seoul, Korea). 2012 Sep; 8(3):235-7. doi: 10.3988/jcn.2012.8.3.235. [PMID: 23091535]
  • Hugh J McMillan, Basil T Darras, Peter B Kang. Autoimmune neuromuscular disorders in childhood. Current treatment options in neurology. 2011 Dec; 13(6):590-607. doi: 10.1007/s11940-011-0146-5. [PMID: 21912840]
  • Zsuzsanna Pál, Judit Boczán, Benjamin Bereznai, Gábor Lovas, Mária Judit Molnár. [Therapy for anti-MuSK antibody positive myasthenia gravis]. Orvosi hetilap. 2011 Sep; 152(39):1586-9. doi: 10.1556/oh.2011.29177. [PMID: 21920845]
  • Mariángela Vargas, Alvaro Segura, María Herrera, Mauren Villalta, Ricardo Estrada, Maykel Cerdas, Owen Paiva, Teatulohi Matainaho, Simon D Jensen, Kenneth D Winkel, Guillermo León, José María Gutiérrez, David J Williams. Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea. PLoS neglected tropical diseases. 2011 May; 5(5):e1144. doi: 10.1371/journal.pntd.0001144. [PMID: 21610854]
  • Maria F Finnis, Sandeep Jayawant. Juvenile myasthenia gravis: a paediatric perspective. Autoimmune diseases. 2011; 2011(?):404101. doi: 10.4061/2011/404101. [PMID: 22110902]
  • T Stojkovic, A Béhin. [Ocular myasthenia: diagnosis and treatment]. Revue neurologique. 2010 Dec; 166(12):987-97. doi: 10.1016/j.neurol.2010.08.004. [PMID: 21075410]
  • Beyazit Zencirci. Sertraline-induced pseudocholinesterase enzyme deficiency. International journal of general medicine. 2010 Nov; 3(?):375-8. doi: 10.2147/ijgm.s14365. [PMID: 21189834]
  • Sorin J Brull, Mohamed Naguib. Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex. Drug design, development and therapy. 2009 Sep; 3(?):119-29. doi: 10.2147/dddt.s3868. [PMID: 19920928]
  • Mitsuaki Shioyama, Haruo Ueda, Hiromi Aomatsu, Yoshiyuki Mitui, Yoshito Naiki, Kenichi Samejima, Masanori Funauchi, Hirokazu Shiraishi, Masakatsu Motomura, Susumu Kusunoki. [Anti-MuSK antibody-positive myasthenia gravis with nephrotic syndrome: a case report]. Rinsho shinkeigaku = Clinical neurology. 2009 Jul; 49(7):424-7. doi: 10.5692/clinicalneurol.49.424. [PMID: 19715171]
  • Shin Joong Oh. Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status. Journal of clinical neurology (Seoul, Korea). 2009 Jun; 5(2):53-64. doi: 10.3988/jcn.2009.5.2.53. [PMID: 19587811]
  • Yehonatan Sharabi, Richard Imrich, Courtney Holmes, Sandra Pechnik, David S Goldstein. Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension. Movement disorders : official journal of the Movement Disorder Society. 2008 Sep; 23(12):1725-32. doi: 10.1002/mds.22226. [PMID: 18661549]
  • Takashi Kurokawa, Takehiko Nishiyama, Ryoo Yamamoto, Hitaru Kishida, Yasuhito Hakii, Yoshiyuki Kuroiwa. [Anti-MuSK antibody positive myasthenia gravis with HIV infection successfully treated with cyclosporin: a case report]. Rinsho shinkeigaku = Clinical neurology. 2008 Sep; 48(9):666-9. doi: 10.5692/clinicalneurol.48.666. [PMID: 19048951]
  • Hidenori Kawasaki, Kensei Yahata, Chinatsu Okamoto, Hirotaka Imamaki, Koichi Seta, Akira Sugawara. [Myasthenia-like syndrome induced by cibenzoline overdose in a patient with chronic kidney disease]. Nihon Jinzo Gakkai shi. 2008; 50(7):942-7. doi: NULL. [PMID: 19069153]
  • Vern C Juel, Janice M Massey. Myasthenia gravis. Orphanet journal of rare diseases. 2007 Nov; 2(?):44. doi: 10.1186/1750-1172-2-44. [PMID: 17986328]
  • Yutaka Nakahama, Masakazu Kawajiri, Masayuki Ochi, Katsuhiko Kohara, Kiyoe Ohta, Tetsurou Miki. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report]. Rinsho shinkeigaku = Clinical neurology. 2007 Jun; 47(6):356-8. doi: . [PMID: 17633110]
  • Hans D de Boer, Jan van Egmond, Jacques J Driessen, Leo H D Booij. Update on the management of neuromuscular block: focus on sugammadex. Neuropsychiatric disease and treatment. 2007; 3(5):539-44. doi: NULL. [PMID: 19300584]
  • Maki Sunayama, Katsuichi Miyamoto, Mitsuaki Shioyama, Takao Sato, Susumu Kusunoki. [A case of myasthenia gravis appearing after thymomectomy: with histopathological investigation]. No to shinkei = Brain and nerve. 2006 Jul; 58(7):615-9. doi: NULL. [PMID: 16910471]
  • Barbara Emeryk-Szajewska, Halina Strugalska-Cynowska, Beata Zakrzewska-Pniewska, Beata Szyluk, Anna Kostera-Pruszczyk. [A case of the Lambert-Eaton syndrome of non-neoplastic origin. Ten-year follow-up]. Neurologia i neurochirurgia polska. 2006 May; 40(3):243-7. doi: . [PMID: 16794965]
  • Peter J Dickinson, Beverly K Sturges, G Diane Shelton, Richard A LeCouteur. Congenital myasthenia gravis in Smooth-Haired Miniature Dachshund dogs. Journal of veterinary internal medicine. 2005 Nov; 19(6):920-3. doi: 10.1892/0891-6640(2005)19[920:cmgism]2.0.co;2. [PMID: 16355692]
  • Robert N Schwendimann, Eric Burton, Alireza Minagar. Management of myasthenia gravis. American journal of therapeutics. 2005 May; 12(3):262-8. doi: NULL. [PMID: 15891271]
  • Adnan I Qureshi, Mohammad A Choundry, Yousef Mohammad, Hoe C Chua, Abutaher M Yahia, John A Ulatowski, David A Krendel, Robert T Leshner. Respiratory failure as a first presentation of myasthenia gravis. Medical science monitor : international medical journal of experimental and clinical research. 2004 Dec; 10(12):CR684-9. doi: . [PMID: 15567987]
  • R Webster, M Brydson, R Croxen, J Newsom-Davis, A Vincent, D Beeson. Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome. Neurology. 2004 Apr; 62(7):1090-6. doi: 10.1212/01.wnl.0000118205.99701.41. [PMID: 15079006]
  • Ashima Saxena, Regina S Hur, Chunyuan Luo, Bhupendra P Doctor. Natural monomeric form of fetal bovine serum acetylcholinesterase lacks the C-terminal tetramerization domain. Biochemistry. 2003 Dec; 42(51):15292-9. doi: 10.1021/bi030150x. [PMID: 14690439]
  • Amelia Evoli, Pietro A Tonali, Luca Padua, Mauro Lo Monaco, Flavia Scuderi, Anna P Batocchi, Mariapaola Marino, Emanuela Bartoccioni. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain : a journal of neurology. 2003 Oct; 126(Pt 10):2304-11. doi: 10.1093/brain/awg223. [PMID: 12821509]
  • Glynis Johnson, Samuel W Moore. Idiotypic mimicry of a catalytic antibody active site. Molecular immunology. 2002 Oct; 39(5-6):273-88. doi: 10.1016/s0161-5890(02)00113-x. [PMID: 12220886]
  • J Finsterer, I Oberman, A Reitner. Respiratory chain complex-I defect mimicking myasthenia. Metabolic brain disease. 2002 Mar; 17(1):41-6. doi: 10.1023/a:1014052330663. [PMID: 11893008]
  • Małgorzata Bilińska. [Seronegative myasthenia gravis]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 2002 Jan; 12(67):49-53. doi: NULL. [PMID: 11957803]
  • N Kanzato, I Nakasone, O Sunagawa, Y Komine, K Fukiyama. [Giant-cell myocarditis without a symptom of heart failure seen in a patient with myasthenia gravis and concurrent Hashimoto's disease]. Rinsho shinkeigaku = Clinical neurology. 2001 Nov; 41(11):813-7. doi: . [PMID: 12080616]
  • O Cohen, C Kronman, T Chitlaru, A Ordentlich, B Velan, A Shafferman. Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity. The Biochemical journal. 2001 Aug; 357(Pt 3):795-802. doi: 10.1042/0264-6021:3570795. [PMID: 11463350]
  • K Uehara, M Kobayashi, A Hirasaki, Y Asao, O Kobayashi. [Myasthenia gravis is improved temporarily at postburn period]. Masui. The Japanese journal of anesthesiology. 2001 May; 50(5):521-4. doi: NULL. [PMID: 11424470]
  • H Sakuma, S Shimazaki, H Saito, M Ohuchi. [A patient with facioscapulohumeral muscular dystrophy accompanied by myasthenia gravis]. Rinsho shinkeigaku = Clinical neurology. 2001 Apr; 41(4-5):179-83. doi: NULL. [PMID: 11676158]
  • J Szenohradszky, D Fogarty, H Kirkegaard-Nielsen, R Brown, M L Sharma, D M Fisher. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium. Anesthesiology. 2000 Mar; 92(3):708-14. doi: 10.1097/00000542-200003000-00015. [PMID: 10719950]
  • C Luo, A Saxena, M Smith, G Garcia, Z Radić, P Taylor, B P Doctor. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium. Biochemistry. 1999 Aug; 38(31):9937-47. doi: 10.1021/bi9905720. [PMID: 10433700]
  • M S García-Ayllón, J L Gómez, C J Vidal. Amphiphilic properties of acetylcholinesterase monomers in mouse plasma. Neuroscience letters. 1999 Apr; 265(3):211-4. doi: 10.1016/s0304-3940(99)00252-9. [PMID: 10327168]
  • C Luo, Y Ashani, B P Doctor. Acceleration of oxime-induced reactivation of organophosphate-inhibited fetal bovine serum acetylcholinesterase by monoquaternary and bisquaternary ligands. Molecular pharmacology. 1998 Apr; 53(4):718-26. doi: 10.1124/mol.53.4.718. [PMID: 9547363]
  • A Bartunek, H Gilly, G Huemer, S Yildiz, W Schramm, F X Lackner, F F Foldes. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade]. Der Anaesthesist. 1997 Feb; 46(2):96-100. doi: 10.1007/s001010050377. [PMID: 9133184]
  • M J Symington, R K Mirakhur, N Kumar. Neostigmine but not edrophonium prolongs the action of mivacurium. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 1996 Dec; 43(12):1220-3. doi: 10.1007/bf03013428. [PMID: 8955970]
  • Y J Kao, N D Le. The reversal of profound mivacurium-induced neuromuscular blockade. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 1996 Nov; 43(11):1128-33. doi: 10.1007/bf03011839. [PMID: 8922768]
  • N W Fleming, S Macres, J F Antognini, J Vengco. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine. British journal of anaesthesia. 1996 Oct; 77(4):492-5. doi: 10.1093/bja/77.4.492. [PMID: 8942334]
  • M Naguib, A H Samarkandi, H S Bakhamees, A Turkistani, S W Alharby. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block. British journal of anaesthesia. 1996 Sep; 77(3):424-6. doi: 10.1093/bja/77.3.424. [PMID: 8949825]
  • K Yamamoto, Y Sawada, T Iga. Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats. Journal of pharmacokinetics and biopharmaceutics. 1996 Aug; 24(4):327-48. doi: 10.1007/bf02353516. [PMID: 9044164]
  • W B Wastila, R B Maehr, G L Turner, D A Hill, J J Savarese. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats. Anesthesiology. 1996 Jul; 85(1):169-77. doi: 10.1097/00000542-199607000-00023. [PMID: 8694363]
  • A Evoli, A P Batocchi, M Lo Monaco, S Servidei, L Padua, L Majolini, P Tonali. Clinical heterogeneity of seronegative myasthenia gravis. Neuromuscular disorders : NMD. 1996 May; 6(3):155-61. doi: 10.1016/0960-8966(96)00009-0. [PMID: 8784802]
  • M Naguib, M Selim, H S Bakhamees, A H Samarkandi, A Turkistani. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade. Anesthesiology. 1996 May; 84(5):1051-9. doi: 10.1097/00000542-199605000-00006. [PMID: 8623998]
  • P Pessotto, R Liberati, O Petrella, W C Hülsmann. Quaternary nitrogen compounds affect carnitine distribution in rats. Particular emphasis on edrophonium. Biochimica et biophysica acta. 1996 Jan; 1299(2):245-51. doi: 10.1016/0005-2760(96)00212-3. [PMID: 8555270]
  • D R Miller, G Bryson, R J Martineau, J B Kitts, M Curran, P Bragg, J B Watson, K Hull, P Lindsay. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 1995 Nov; 42(11):996-1002. doi: 10.1007/bf03011072. [PMID: 8590511]
  • A Devcic, C A Munshi, S K Gandhi, J P Kampine. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium. Anesthesia and analgesia. 1995 Nov; 81(5):1005-9. doi: 10.1097/00000539-199511000-00019. [PMID: 7486038]
  • K Yamamoto, Y Sawada, T Iga. Comparative pharmacokinetics of four cholinesterase inhibitors in rats. Biological & pharmaceutical bulletin. 1995 Sep; 18(9):1292-5. doi: 10.1248/bpb.18.1292. [PMID: 8845827]
  • E P McCoy, R K Mirakhur. Comparison of the effects of neostigmine and edrophonium on the duration of action of suxamethonium. Acta anaesthesiologica Scandinavica. 1995 Aug; 39(6):744-7. doi: 10.1111/j.1399-6576.1995.tb04163.x. [PMID: 7484027]
  • C A Kernich, H J Kaminski. Myasthenia gravis: pathophysiology, diagnosis and collaborative care. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. 1995 Aug; 27(4):207-15; quiz 216. doi: 10.1097/01376517-199508000-00003. [PMID: 7499922]
  • P S Hart, P M Wright, R Brown, M Lau, M L Sharma, R D Miller, L Gruenke, D M Fisher. Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis. Anesthesiology. 1995 Apr; 82(4):912-8. doi: 10.1097/00000542-199504000-00014. [PMID: 7717563]
  • G A Khan, N Bank. Interpretation of positive edrophonium (Tensilon) test in patients with end-stage renal disease. Renal failure. 1995 Jan; 17(1):65-71. doi: 10.3109/08860229509036377. [PMID: 7770646]
  • M W Platt. Mivacurium in short to intermediate surgical procedures. Acta anaesthesiologica Scandinavica. Supplementum. 1995; 106(?):30-4. doi: 10.1111/j.1399-6576.1995.tb04306.x. [PMID: 8533542]
  • C S Yost, E Maestrone. Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor. Anesthesia and analgesia. 1994 Mar; 78(3):520-6. doi: 10.1213/00000539-199403000-00018. [PMID: 8109771]
  • J P Azulay, J Pouget, D Figarella-Branger, R Colamarino, J F Pellissier, G Serratrice. [Isolated proximal muscular weakness disclosing myasthenic syndrome]. Revue neurologique. 1994; 150(5):377-81. doi: . [PMID: 7878325]
  • B Velan, C Kronman, A Ordentlich, Y Flashner, M Leitner, S Cohen, A Shafferman. N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis. The Biochemical journal. 1993 Dec; 296 ( Pt 3)(?):649-56. doi: 10.1042/bj2960649. [PMID: 8280063]
  • D C Smith, S A Ridley, K F Donaldson. Fresh frozen plasma and edrophonium in a patient with a plasma cholinesterase deficiency. Anaesthesia. 1993 Jun; 48(6):511-3. doi: 10.1111/j.1365-2044.1993.tb07073.x. [PMID: 8391759]
  • F S Jensen, J Viby-Mogensen. Reaction to succinylcholine in two patients segregating for the plasma cholinesterase allele Ek. Acta anaesthesiologica Scandinavica. 1992 Nov; 36(8):753-7. doi: 10.1111/j.1399-6576.1992.tb03558.x. [PMID: 1334612]
  • P Cortelli, P Parchi, M Contin, E Sforza, A Lugaresi, R Pasquali, E Lugaresi. Isolated failure of noradrenergic transmission in a case with orthostatic hypotension and hyperactivity of gastro-colic reflex. Clinical autonomic research : official journal of the Clinical Autonomic Research Society. 1992 Jun; 2(3):177-82. doi: 10.1007/bf01818959. [PMID: 1323364]
  • I Funakawa, T Yasuda, H Katoh, K Hara, A Terao. [A case of bilateral blepharospasm responsive to edrophonium]. Rinsho shinkeigaku = Clinical neurology. 1992 May; 32(5):527-31. doi: . [PMID: 1458732]
  • R S Matteo, W L Young, E Ornstein, A E Schwartz, P A Silverberg, J Diaz. Pharmacokinetics and pharmacodynamics of edrophonium in elderly surgical patients. Anesthesia and analgesia. 1990 Oct; 71(4):334-9. doi: 10.1213/00000539-199010000-00003. [PMID: 2169210]
  • R D Rey, O P Sanz, J M Fernández, R C Rey, M Panizza, N Lucilli, M A Astudillo, G Diaz, A H Villegas, R E Sica. [Diagnosis and treatment of myasthenia gravis: study of an inpatient population]. Arquivos de neuro-psiquiatria. 1990 Sep; 48(3):270-8. doi: 10.1590/s0004-282x1990000300002. [PMID: 2264781]
  • H Sato, S Araki. [Myasthenia gravis]. Nihon rinsho. Japanese journal of clinical medicine. 1990 Jul; 48(7):1470-6. doi: NULL. [PMID: 2402064]
  • J N Cashman, J J Luke, R M Jones. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function. British journal of anaesthesia. 1990 Feb; 64(2):186-92. doi: 10.1093/bja/64.2.186. [PMID: 2138489]
  • C S Payne, M Saeed, A D Wolfe. Ligand stabilization of cholinesterases. Biochimica et biophysica acta. 1989 Nov; 999(1):46-51. doi: 10.1016/0167-4838(89)90028-9. [PMID: 2804138]
  • O Dériaz, C A Nacht, R Chioléro, E Jéquier, K J Acheson. The parasympathetic nervous system and the thermic effect of glucose/insulin infusions in humans. Metabolism: clinical and experimental. 1989 Nov; 38(11):1082-8. doi: 10.1016/0026-0495(89)90044-9. [PMID: 2682136]
  • J D Gemmill, G S Venables, D J Ewing. Noradrenaline response to edrophonium in primary autonomic failure: distinction between central and peripheral damage. Lancet (London, England). 1988 May; 1(8593):1018-21. doi: 10.1016/s0140-6736(88)91842-9. [PMID: 2896869]
  • R J Joseph, J M Carrillo, V A Lennon. Myasthenia gravis in the cat. Journal of veterinary internal medicine. 1988 Apr; 2(2):75-9. doi: 10.1111/j.1939-1676.1988.tb02797.x. [PMID: 3221361]
  • D M Matthews, C N Martyn, R A Riemersma, B F Clarke, D J Ewing. Noradrenaline response to edrophonium (Tensilon) and its relation to other autonomic tests in diabetic subjects. Diabetes research (Edinburgh, Scotland). 1987 Dec; 6(4):175-80. doi: . [PMID: 3447810]
  • L Tappy, R Chiolero, J P Randin, P Burckhardt, J P Felber. Effects of cholinergic stimulation and antagonism on plasma insulin concentration in lean and obese human subjects. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 1986 Dec; 18(12):821-6. doi: 10.1055/s-2007-1012448. [PMID: 3546047]
  • R L Carpenter, M F Mulroy. Edrophonium antagonizes combined lidocaine-pancuronium and verapamil-pancuronium neuromuscular blockade in cats. Anesthesiology. 1986 Nov; 65(5):506-10. doi: 10.1097/00000542-198611000-00009. [PMID: 3777479]
  • R K Mirakhur. Edrophonium and plasma cholinesterase activity. Canadian Anaesthetists' Society journal. 1986 Sep; 33(5):588-90. doi: 10.1007/bf03014265. [PMID: 3768766]
  • S M Aquilonius, P Hartvig. Clinical pharmacokinetics of cholinesterase inhibitors. Clinical pharmacokinetics. 1986 May; 11(3):236-49. doi: 10.2165/00003088-198611030-00005. [PMID: 3524957]
  • M S Sellman, R F Mayer. Treatment of myasthenic crisis in late life. Southern medical journal. 1985 Oct; 78(10):1208-10. doi: 10.1097/00007611-198510000-00017. [PMID: 4049040]
  • A A Ajayi, B C Campbell, C A Howie, J L Reid. Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man. Journal of hypertension. 1985 Feb; 3(1):47-53. doi: 10.1097/00004872-198502000-00008. [PMID: 2987341]
  • B C Campbell, A Sturani, J L Reid. Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man. Clinical science (London, England : 1979). 1985 Jan; 68(1):49-56. doi: 10.1042/cs0680049. [PMID: 3880523]
  • P J Hennis, R Cronnelly, M Sharma, D M Fisher, R D Miller. Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog. Anesthesiology. 1984 Nov; 61(5):534-9. doi: 10.1097/00000542-198411000-00010. [PMID: 6149707]
  • L M Miller, V A Lennon, E H Lambert, S M Reed, G A Hegreberg, J B Miller, R L Ott. Congenital myasthenia gravis in 13 smooth fox terriers. Journal of the American Veterinary Medical Association. 1983 Apr; 182(7):694-7. doi: NULL. [PMID: 6841251]
  • L W Haynes, M E Smith. Selective inhibition of 'motor endplate-specific' acetylcholinesterase by beta-endorphin and related peptides. Neuroscience. 1982 Apr; 7(4):1007-13. doi: 10.1016/0306-4522(82)90057-4. [PMID: 6285223]
  • W Trojaborg, A Flagstad. A hereditary neuromuscular disorder in dogs. Muscle & nerve. 1982; 5(9S):S30-8. doi: NULL. [PMID: 7169998]
  • R B Morris, R Cronnelly, R D Miller, D R Stanski, M R Fahey. Pharmacokinetics of edrophonium in anephric and renal transplant patients. British journal of anaesthesia. 1981 Dec; 53(12):1311-4. doi: 10.1093/bja/53.12.1311. [PMID: 7032560]
  • M G De Ruyter, R Cronnelly. Reversed-phase, ion-pair liquid chromatography of quaternary ammonium compounds: determination of pyridostigmine, neostigmine and edrophionium in biological fluids. Journal of chromatography. 1980 Aug; 183(2):193-201. doi: 10.1016/s0378-4347(00)81693-x. [PMID: 7400278]
  • S A Leveston, P E Cryer. Endogenous cholinergic modulation of growth-hormone secretion in normal and acromegalic humans. Metabolism: clinical and experimental. 1980 Aug; 29(8):703-6. doi: 10.1016/0026-0495(80)90191-2. [PMID: 7402075]
  • D De Grandis, C Mezzina, A Fiaschi, P Pinelli, G Bazzato, M Morachiello. Myasthenia due to carnitine treatment. Journal of the neurological sciences. 1980 Jun; 46(3):365-71. doi: 10.1016/0022-510x(80)90061-1. [PMID: 7381520]
  • H E Barber, T N Calvey, K T Muir. The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium. British journal of pharmacology. 1979 Aug; 66(4):525-30. doi: 10.1111/j.1476-5381.1979.tb13690.x. [PMID: 223706]
  • S A Leveston, S D Shah, P E Cryer. Cholinergic stimulation of norepinephrine release in man. Evidence of a sympathetic postganglionic axonal lesion in diabetic adrenergic neuropathy. The Journal of clinical investigation. 1979 Aug; 64(2):374-80. doi: 10.1172/jci109471. [PMID: 457858]
  • J P Palmer, P L Werner, P Hollander, J W Ensinck. Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man. Metabolism: clinical and experimental. 1979 May; 28(5):549-52. doi: 10.1016/0026-0495(79)90196-3. [PMID: 449696]
  • R D Tolin, G Boden, R S Fisher. Effects of endogenous hyperglucagonemia on lower esophageal sphincter pressure and gastric acid secretion. Digestive diseases and sciences. 1979 Apr; 24(4):296-304. doi: 10.1007/bf01296544. [PMID: 222559]
  • O Leiva, F Lozano, C Ramos, P Paniagua, V Borobia. [Diagnosis of renal angiomyolipoma by means of computerized axial tomography]. Actas urologicas espanolas. 1979 Jan; 3(1):43-6. doi: NULL. [PMID: 452977]
  • R S Fisher, G S Roberts, C J Grabowski, S Cohen. Altered lower esophageal sphincter function during early pregnancy. Gastroenterology. 1978 Jun; 74(6):1233-7. doi: . [PMID: 648814]
  • B M Patten. Myasthenia gravis: review of diagnosis and management. Muscle & nerve. 1978 May; 1(3):190-205. doi: 10.1002/mus.880010304. [PMID: 86952]
  • E P Bosch, P E Reith, D K Granner. Myasthenia gravis and Schmidt syndrome. Neurology. 1977 Dec; 27(12):1179-80. doi: 10.1212/wnl.27.12.1179. [PMID: 563019]
  • K G Henriksson, O Nilsson, I Rosén, H H Schiller. Clinical, neurophysiological and morphological findings in Eaton Lambert syndrome. Acta neurologica Scandinavica. 1977 Aug; 56(2):117-40. doi: 10.1111/j.1600-0404.1977.tb01417.x. [PMID: 899716]
  • Y Hashimoto, T Shima, S Matsukawa. Effect of plasma-cholinesterase preparation on the phase II block of succinylcholine chloride in man. The Tohoku journal of experimental medicine. 1977 Jul; 122(3):301-2. doi: 10.1620/tjem.122.301. [PMID: 918967]